NPC Healthbiz Weekly

S15 E01 What Keeps Pharma Companies Up At Night

Pangaea Consultants’ Managing Director Jeff Martens discusses going from an operating role to consulting, lack of access in today’s political climate…

Jan 21 • Jeremy Visser

31:15

The next chapter in obesity treatment: Sustainability and scale

With breakthrough agents established, the challenge now is demonstrating real-world endurance, long-term outcomes, and chronic disease management (Issue…

Jan 20 • Cristela Tello Ruiz

1

How Canada's DTC regulations forced a smarter (and more profitable?) patient strategy

Canada’s strict DTC laws have forced a shift from product promotion to patient journey ownership (Issue #352, 1200 words, 6 minutes)

Jan 13 • Cristela Tello Ruiz

December 2025

From novel milestones to niche breakthroughs: Canada's 2025 drug approvals

Health Canada maintained strong momentum in 2025, clearing innovative therapies while advancing treatments for rare diseases (Issue #351, 1460 words, 7…

Dec 16, 2025 • Cristela Tello Ruiz

1

Generic semaglutide looms as Canada grapples with rising obesity rates

US-based online pharmacy snaps up Montreal digital health platform ahead of semaglutide patent expiry (Issue #350, 1,300 words, 6 minutes)

Dec 9, 2025 • Cristela Tello Ruiz

2

AbbVie to offer Biotech Innovators Award in Quebec

In collaboration with adMare BioInnovations, the AbbVie Biotech Innovators Award will provide one Quebec startup with lab space and mentorship (Issue…

Dec 2, 2025 • Cristela Tello Ruiz

1

November 2025

How disruption is reshaping pharma’s competitive landscape

From AI-driven development to diminishing research funding, experts stress the need for stronger partnerships and data-driven strategies (Issue #348…

Nov 25, 2025 • Cristela Tello Ruiz

1

Canada at a crossroads: Policy changes could mean trouble ahead

Industry leaders warn of growing barriers to innovation, market access, and R&D investment (Issue #348, 1,560 words, 7 minutes)

Nov 18, 2025 • Cristela Tello Ruiz

Charting the next phase of pharma innovation in Canada: The 19th National Pharmaceutical Congress

The National Pharmaceutical Congress 2025 convened life sciences leaders to celebrate new Canadian Healthcare Marketing Hall of Fame inductees. (Issue…

Nov 11, 2025 • Cristela Tello Ruiz

1

Pharma’s talent crunch has arrived. It’s digital

With skills shortages worsening, the fight for professionals who can fuse data science with regulatory strategy is now your company’s biggest…

Nov 3, 2025 • Cristela Tello Ruiz

October 2025

The $300 billion reckoning: Reinventing pharma for the post-patent era

A new patent cliff looms as key product exclusivities expire, heightening urgency for pipeline diversification (Issue #347, 2,200 words, 6 minutes)

Oct 28, 2025 • Cristela Tello Ruiz

1

S14 E08 Seaford Pharmaceuticals’ Journey as a Family-owned Canadian Company

Listen now | Seaford President Tamara Seales discusses navigating Canadian pharma regulations, team-building, and weaving DEI into the fabric of the…

Oct 22, 2025 • Jeremy Visser

33:20